Status:

COMPLETED

Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy

Lead Sponsor:

Ankara Etlik City Hospital

Conditions:

Ovarian Cancer (OvCa)

Fallopian Tube Cancers

Eligibility:

FEMALE

18+ years

Brief Summary

This observational study aims to evaluate chemotherapy-induced taste alterations, sarcopenia, and malnutrition in patients with gynecologic malignancies (ovarian, fallopian tube, and endometrial cance...

Detailed Description

Gynecologic malignancies, including ovarian, fallopian tube, and endometrial cancers, are among the leading causes of morbidity and mortality in women. Standard first-line treatment with carboplatin a...

Eligibility Criteria

Inclusion

  • Histologically confirmed diagnosis of non-metastatic ovarian, fallopian tube, or endometrial cancer
  • Planned to receive adjuvant or neoadjuvant carboplatin-paclitaxel regimen (carboplatin AUC 5 + paclitaxel 175-200 mg/m² every 21 days)
  • No prior chemotherapy
  • Age ≥ 18 years, female
  • Completion of 6 cycles of carboplatin-paclitaxel treatment
  • Availability of CT imaging at baseline, after third cycle, and after sixth cycle
  • Ability to provide written informed consent

Exclusion

  • Metastatic disease or palliative treatment setting
  • Treatment with regimens other than carboplatin-paclitaxel or weekly protocols
  • Prior systemic therapy (e.g., immunotherapy, targeted therapy) Initial treatment discontinuation due to progression, toxicity, or patient preference
  • Missing CT imaging at required timepoints
  • Pregnancy or breastfeeding
  • Cognitive impairment or inability to provide informed consent
  • Severe comorbid conditions (e.g., uncontrolled cardiac disease, end-stage renal failure, advanced liver failure)
  • Inability to comply with study assessments or follow-up visits

Key Trial Info

Start Date :

March 15 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2025

Estimated Enrollment :

102 Patients enrolled

Trial Details

Trial ID

NCT07154966

Start Date

March 15 2024

End Date

July 1 2025

Last Update

September 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ankara Etlik City Hospital

Ankara, Yenimahalle, Turkey (Türkiye), 06210